StaffRoméo Arago Dougué Kentsop


Informations



E-mail
dougue@ibba.cnr.it

Phone
+39 0223699426

Office
Milano


Research Gate: Profile
Linkedin: Roméo Arago Dougué Kentsop

Dougué Kentsop Roméo Arago

Research fellow

Education

2016 – 2019: PhD in Pharmaceutical, Nutritional and Cosmetic Sciences at the Department of Pharmacy of University of Genoa. Title: Biotechnology applied to aromatic plants for the controlled production of bioactive compounds.

2012 – 2015: Master in Pharmacy at the Department of Pharmacy University of Urbino. Title: The use of vegetable origin products in the galenic field.

2009 – 2012: Bachelor in Biomedical Sciences at the Department of Biomedical Sciences of University of Dschang

Professional experience

2019-Now: Research assistant at IBBA- CNR. Project INFLAME.

2017 – 2019: Teaching assistant in Technology, Socioeconomics and Pharmaceutical Legislation at theDepartment of Pharmacy of University of Genoa.

2017 – 2018: Teaching assistant in Drug Analysis at the Department of Pharmacy of University of Genoa.

Research interests

  • In vitro culture of tissues, cells and medicinal plants.
  • Quality and quantitative analysis of secondary metabolites, pathways of biosynthesis, biological activities.

Projects in progress

Projects completed

InFlaMe - Improvement of secondary metabolites production for human health by flax cell in vitro technology
Start date: 01/09/2017   End date: 30/06/2021

Fondazione Cariplo

Milano   Website

Monica Mattana

Project duration:
01/09/2017 - 30/06/2021
Financing body:
Fondazione Cariplo
Project research leader:
Monica Mattana
Headquarters:
Milano
Project website:
Website

InFlaMe - Improvement of secondary metabolites production for human health by flax cell in vitro technology


The aim of the InFlaMe project is to optimize the production of secondary metabolites of pharmacological/nutraceutical interest, the lignans which are produced at low concentration by flax plants as defense compounds against herbivores and microrganisms. To this purpose a biotechnological approach will be used starting from the production of different plant tissue cultures obtained from several diverse flax species. The obtained cultures will be induced to an increased production of lignans through the use of specific elicitors and through metabolic engineering.

In the long term this technology will provide a large scale production of high added value compounds currently limited by the low potential of producer species.

 

Istituto

Search website